DGAP-News: True Leaf Medicine International Ltd

DGAP-News: True Leaf Medicine International Ltd. arranges $225,000 private placement

DGAP-News: True Leaf Medicine International Ltd. / Key word(s): Financing/Capital Increase True Leaf Medicine International Ltd. arranges $225,000 private placement

04.01.2016 / 15:31 The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

2016-01-04 TRUE LEAF MEDICINE INTERNATIONAL LTD. OFFERS $225,000 NON BROKERED PRIVATE PLACEMENT True Leaf Medicine International Ltd. has arranged a non-brokered private placement of up to 2.142.857 units at a subscription price of $0.10.5 per unit to eligible subscribers for gross proceeds of up to $225,000. Each unit will consist of one common share and one half share purchase warrant. Each whole warrant will be exercisable into one additional common share of the company at $ 0.15 cents per warrant share for a period of 24 months from the closing. The common shares issued or issuable pursuant to the private placement will be restricted from trading for a four-month hold period in accordance with applicable securities laws and, if required, the policies of the exchange. The proceeds of this private placement will be used to facilitate a move to a larger scale manufacturing facility in Ontario, Canada as well as general working capital. About True Leaf True Leaf Medicine International Ltd is a Canadian medical marijuana company carving a niche in the fast growing and dynamic $60 billion pet industry. A subsidiary, True Leaf Pet, will focus on the natural pet product sector with a line consisting of innovative hemp based functional pet chews, followed by CBD supplements for pets in the USA market. This will lay a profitable foundation for the company's long term strategy to secure a new animal drug application for a cannabis-based pet medication sold via veterinary prescription in the $13.8 billion pet medication market. Contact: Kevin Bottomley Director True Leaf Medicine International Ltd M: +1 778 389 9933 kevin@trueleaf.com

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. FORWARD LOOKING INFORMATION This press release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Company's Management's Discussion and Analysis under the Company's profile on www.sedar.com. While the Company may elect to, it does not undertake to update this information at any particular time.

---------------------------------------------------------------------------

04.01.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------

Language: English Company: True Leaf Medicine International Ltd. 32 - 100 Kalamalka Lake Road V1T 9 G1 Vernon (BC) Canada Phone: +17783899933 E-mail: kevin@trueleaf.com Internet: www.trueleaf.com ISIN: CA89785C1077, CA89785C1077 WKN: , A0Q3EE Listed: Regulated Unofficial Market in Berlin, Berlin - Equiduct Trading, Munich, Stuttgart; Open Market in Frankfurt ; Canadian Venture Exchange End of News DGAP News Service ---------------------------------------------------------------------------

426813 04.01.2016